A cellular key to the gastric inflammation-metaplasia-carcinoma sequence?

胃炎症-化生-癌序列的细胞关键?

基本信息

  • 批准号:
    7177229
  • 负责人:
  • 金额:
    $ 11.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-01-01 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Gastric cancer is one of the most frequent causes of cancer-related death world wide. Chronic inflammation as a result of Helicobacter pylori infection is an important initiating factor in a sequence that develops over years and progresses from atrophic gastritis, intestinal metaplasia, dysplasia and finally, adenocarcinoma. It has been speculated that the mutational changes that finally result in gastric cancer originate in the stem cell compartment; thus, characterization of gastric stem cells is an important clinical goal. However, the prospective recognition and isolation of gastric stem cells has been heretofore impossible because of the lack of specific markers for these cells. Moreover, the tools necessary to trace the progeny of single gastric progenitor cells (to establish definitively whether these cells give rise to gastric tumors) have not been available. Data presented here show that the mouse villin promoter is active in a subpopulation of gastric cells that exhibit characteristics of progenitor or stem cells; the cells are called pGPC (putative gastric progenitor cells). pGPC arise early in development and are found throughout life in epithelial compartments known to contain stem cells. Lineage tracing experiments in situ suggest that pGPC have multi-lineage potential. Interestingly, interferon gamma (IFNgamma), a potent pro-inflammatory stimulus known to be tightly associated with the development of gastric cancer, causes a robust increase in the number of pGPC. The hypothesis underlying this work is that pGPC are gastric progenitor or stem-like cells and that they play a key role in the "chronic gastritis-intestinal metaplasia-carcinoma" sequence. Thus, the goal of this project is to further characterize pGPC in vivo in murine stomachs and to investigate whether these cells give rise to metaplastic lesions and to gastric tumors. This work can provide major insights into gastrointestinal stem cell biology, an area that has been notoriously difficult to investigate at the single cell level. Moreover, if it is demonstrated that tumors indeed arise from pGPC, this will have enormous implications for the further study and future clinical management of gastric cancer.
描述(由申请人提供):胃癌是世界范围内癌症相关死亡的最常见原因之一。幽门螺杆菌感染引起的慢性炎症是一个重要的起始因素,其发展过程持续多年,并从萎缩性胃炎、肠上皮化生、异型增生发展到腺癌。据推测,最终导致胃癌的突变变化起源于干细胞室;因此,胃干细胞的表征是一个重要的临床目标。然而,由于缺乏特异性标记物,胃干细胞的前瞻性识别和分离迄今为止是不可能的。此外,还没有必要的工具来追踪单个胃祖细胞的后代(以明确确定这些细胞是否会引起胃肿瘤)。本文提供的数据显示,小鼠绒毛蛋白启动子在表现出祖细胞或干细胞特征的胃细胞亚群中是活跃的;这些细胞被称为pGPC(推定的胃祖细胞)。pGPC在发育早期出现,并且在整个生命过程中在已知含有干细胞的上皮隔室中发现。原位谱系示踪实验表明pGPC具有多谱系潜能。有趣的是,干扰素γ(IFN γ),一种已知与胃癌发展密切相关的强效促炎刺激物,导致pGPC数量的强劲增加。这项工作的假设是,pGPC是胃祖细胞或干细胞样细胞,他们在“慢性胃炎-肠化生-癌”序列中发挥关键作用。因此,本项目的目标是进一步表征pGPC在小鼠胃中的体内特性,并研究这些细胞是否引起化生性病变和胃肿瘤。这项工作可以为胃肠道干细胞生物学提供重要的见解,这是一个众所周知的难以在单细胞水平上研究的领域。此外,如果证明肿瘤确实是由pGPC引起的,这将对胃癌的进一步研究和未来的临床管理产生巨大的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBORAH L. GUMUCIO其他文献

DEBORAH L. GUMUCIO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBORAH L. GUMUCIO', 18)}}的其他基金

Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    8666637
  • 财政年份:
    2011
  • 资助金额:
    $ 11.67万
  • 项目类别:
Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    8334484
  • 财政年份:
    2011
  • 资助金额:
    $ 11.67万
  • 项目类别:
Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    9177514
  • 财政年份:
    2011
  • 资助金额:
    $ 11.67万
  • 项目类别:
Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    8261814
  • 财政年份:
    2011
  • 资助金额:
    $ 11.67万
  • 项目类别:
Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    8469857
  • 财政年份:
    2011
  • 资助金额:
    $ 11.67万
  • 项目类别:
Morphogenesis of the fetal intestinal epithelium
胎儿肠上皮的形态发生
  • 批准号:
    8068467
  • 财政年份:
    2010
  • 资助金额:
    $ 11.67万
  • 项目类别:
Cell: Cell Interactions During Late Intestinal Development
细胞:肠道发育后期的细胞相互作用
  • 批准号:
    7850156
  • 财政年份:
    2009
  • 资助金额:
    $ 11.67万
  • 项目类别:
Cell: Cell Interactions During Late Intestinal Development
细胞:肠道发育后期的细胞相互作用
  • 批准号:
    7895241
  • 财政年份:
    2009
  • 资助金额:
    $ 11.67万
  • 项目类别:
A cellular key to the gastric inflammation-metaplasia-carcinoma sequence?
胃炎症-化生-癌序列的细胞关键?
  • 批准号:
    7383918
  • 财政年份:
    2007
  • 资助金额:
    $ 11.67万
  • 项目类别:
Cell: Cell Interactions During Late Intestinal Development
细胞:肠道发育后期的细胞相互作用
  • 批准号:
    6921710
  • 财政年份:
    2005
  • 资助金额:
    $ 11.67万
  • 项目类别:

相似国自然基金

βB1 蛋白 L116P 突变通过 Greek key II 的稳定 性介导晶状体蛋白异常聚集的作用与机制研 究
  • 批准号:
    Q24H120009
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
βB晶状体蛋白第四Greek Key基序调控晶状体蛋白稳态的分子机制
  • 批准号:
    LY23H120004
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于命名数据网络的无线局域网自适应视频流传输关键技术研究
  • 批准号:
    2021JJ30874
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
“Lock and Key”策略构建二元共混体系中粒子刷相互作用新模型研究
  • 批准号:
    51973001
  • 批准年份:
    2019
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
中国同脉缟蝇亚科昆虫的增强性鉴定
  • 批准号:
    31260525
  • 批准年份:
    2012
  • 资助金额:
    48.0 万元
  • 项目类别:
    地区科学基金项目
面向MANET的密钥管理关键技术研究
  • 批准号:
    61173188
  • 批准年份:
    2011
  • 资助金额:
    52.0 万元
  • 项目类别:
    面上项目
加密/签名的密钥泄露保护机制研究
  • 批准号:
    60970111
  • 批准年份:
    2009
  • 资助金额:
    33.0 万元
  • 项目类别:
    面上项目

相似海外基金

Identifying key fire drivers in Australia; biomass, climate or people
确定澳大利亚的主要火灾驱动因素;
  • 批准号:
    DE240100340
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Discovery Early Career Researcher Award
Interplay of the extracellular matrix and immune cells in lung pathology: key role for chitinase-like proteins
肺病理学中细胞外基质和免疫细胞的相互作用:几丁质酶样蛋白的关键作用
  • 批准号:
    MR/Y003683/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Research Grant
Developing Advanced Cryptanalysis Techniques for Symmetric-key Primitives with Real-world Public-key Applications
使用现实世界的公钥应用开发对称密钥原语的高级密码分析技术
  • 批准号:
    24K20733
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
  • 批准号:
    2333683
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Continuing Grant
Collaborative Research: Phenotypic and lineage diversification after key innovation(s): multiple evolutionary pathways to air-breathing in labyrinth fishes and their allies
合作研究:关键创新后的表型和谱系多样化:迷宫鱼及其盟友呼吸空气的多种进化途径
  • 批准号:
    2333684
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Continuing Grant
Bridging the gap between Key-Evolving Signatures and Their Applications
弥合密钥演化签名及其应用之间的差距
  • 批准号:
    DP240100017
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Discovery Projects
Solving key issues in wearable thermoelectrics for practical applications
解决可穿戴热电器件实际应用中的关键问题
  • 批准号:
    DE240100519
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Discovery Early Career Researcher Award
Berberine bridge enzyme-like proteins as key virulence factors in plant pathogens
小檗碱桥酶样蛋白作为植物病原体的关键毒力因子
  • 批准号:
    BB/Y003977/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Research Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Research Grant
Understanding the Key to Unlocking Fast Li-ion Conduction in Fluoride-based Solid Electrolytes
了解氟化物固体电解质中实现快速锂离子传导的关键
  • 批准号:
    2329953
  • 财政年份:
    2024
  • 资助金额:
    $ 11.67万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了